Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,837 shares at $5.54 ($27K) on 2021-05-04, disclosed to the SEC on 2021-05-04.
Open-market sale of $27k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.54 | 1,206 | $7K | 24.9% |
| 2 | $5.54 | 1,448 | $8K | 29.9% |
| 3 | $5.54 | 2,183 | $12K | 45.1% |
| Total | $5.54 avg | 4,837 | $27K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |